Thorogood J, Persijn G G, Schreuder G M, D'Amaro J, Zantvoort F A, van Houwelingen J C, van Rood J J
Eurotransplant Foundation, University Department of Medical Statistics, Leiden, The Netherlands.
Transplantation. 1990 Jul;50(1):146-50. doi: 10.1097/00007890-199007000-00027.
The effect of matching for the HLA antigens has been well established as important in the prognosis of kidney grafts. By analyzing the effect of matching on first transplants from unrelated donors in specific intervals up to 3 years posttransplantation, we show that the effect of HLA-DR matching is strongest in the first 5 months following transplantation (relative risks of graft failure 1.31 and 1.77 for 1 and 2 HLA-DR mismatches, respectively, compared with no mismatches). For patients whose grafts remained functioning after 5 months, there was no significant further improvement in graft survival to 3 years (relative risks 1.16 and 0.98 for 1 and 2 HLA-DR mismatches, respectively, compared with no mismatches)--i.e., the gain in graft survival by matching for HLA-DR appears to be due to its influence in the first 5 months following transplantation. For HLA-B, the matching effect was evident both before and after 5 months (relative risks 1.11 and 1.27 for 1 and 2 HLA-B mismatches, respectively, compared with no mismatches and modelled as constant over the 3-year period), whereas no effect of HLA-A matching was evident in the period up to 3 years.
人类白细胞抗原(HLA)抗原配型的作用在肾移植预后方面已被充分证实是重要的。通过分析配型对来自无关供体的首次移植在移植后长达3年的特定时间段内的影响,我们发现HLA - DR配型的作用在移植后的前5个月最强(与无错配相比,1个和2个HLA - DR错配的移植失败相对风险分别为1.31和1.77)。对于移植后5个月仍有功能的患者,移植存活至3年并无显著进一步改善(与无错配相比,1个和2个HLA - DR错配的相对风险分别为1.16和0.98)——即,通过HLA - DR配型获得的移植存活获益似乎归因于其在移植后前5个月的影响。对于HLA - B,配型效果在5个月前后均明显(与无错配相比,1个和2个HLA - B错配的相对风险分别为1.11和1.27,并在3年期间建模为恒定);而在长达3年的时间段内,HLA - A配型无明显效果。